Projects per year
Personal profile
Education
- 2011 Ph.D. in National Heart and Lung Institute, Imperial College London
- 2001 B.S. in Department of Agronomy, National Chung Hsing University
Experience
- 2022- Associate Professor, Graduate Institute of Biomedical Informatics, Taipei Medical University
- 2017-2022 Assistant Professor, Graduate Institute of Biomedical Informatics, Taipei Medical University
- 2015-2017 Assistant Professor, Ph.D. Program for Translational Medicine, Taipei Medical University
Related Link
Fingerprint
Dive into the research topics where Shu-Chun Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Investigate Immunomodulatory Mechanisms Involved in Bzdr-Promoted Breast Carcinogenesis
Chang, S.-C. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
Fbxo32 and Fbxl22 Suppress Nsclc via Modulating Ubiquitin Machinery and Tumor Microenvironment
Chang, S.-C. (PI)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
Investigate Hiltonol-Mediated Anticancer Mechanisms in Nsclc
Chang, S.-C. (PI)
8/1/21 → 7/31/22
Project: A - Government Institution › b - National Science and Technology Council
-
To Investigate the Role of Hiltonol-Based Combinatorial Treatment in Lung Cancer Survival/Death, Metastasis and Tumorigenic Microenvironment.
Chang, S.-C. (PI)
8/1/20 → 7/1/21
Project: A - Government Institution › b - National Science and Technology Council
-
The Role of Intracellular and Extracellular Ubiquitin Machinery in Modulation of Breast Cancer Tumorigenesis, Metastasis and Tumour Microenvironment
Chang, S.-C. (PI)
8/1/18 → 7/31/20
Project: A - Government Institution › b - National Science and Technology Council
-
Long-term treatment with benzodiazepines and related Z-drugs exacerbates breast cancer: clinical evidence and molecular mechanisms
Yang, W.-C. V., Lin, Y.-Y., Ding, J. L., Hung, C.-S., Nguyen, P.-A., Zhang, B.-X., Hsieh, T.-H. & Chang, S.-C., Jun 29 2025, In: Cellular and Molecular Biology Letters. 30, 1, p. 75Research output: Contribution to journal › Article › peer-review
-
PD-1/PD-L1 Cancer Immunotherapeutics Reshape Tumor Microenvironment - Clinical Evidence and Molecular Mechanisms for AI-based Precision Medicine
Lin, Y.-Y., Ding, J. L., Shen, H.-T., Lin, Y.-M., Adhidjaja, E. C. & Chang, S.-C., Oct 17 2025, In: Clinical Reviews in Allergy and Immunology. 68, 1, p. 91Research output: Contribution to journal › Review article › peer-review
-
E2-E3 ubiquitin enzyme pairing - partnership in provoking or mitigating cancers
Chang, S. C., Zhang, B. X. & Ding, J. L., Mar 2022, In: Biochimica et Biophysica Acta - Reviews on Cancer. 1877, 2, 188679.Research output: Contribution to journal › Review article › peer-review
Open Access20 Citations (Scopus) -
A novel signature of ccnf-associated e3 ligases collaborate and counter each other in breast cancer
Chang, S. C., Hung, C. S., Zhang, B. X., Hsieh, T. H., Hsu, W. & Ding, J. L., Jun 2 2021, In: Cancers. 13, 12, 2873.Research output: Contribution to journal › Article › peer-review
Open Access17 Citations (Scopus) -
Hiltonol cocktail kills lung cancer cells by activating cancer-suppressors, pkr/oas and restraining the tumor microenvironment
Chang, S. C., Zhang, B. X., Su, E. C. Y., Wu, W. C., Hsieh, T. H., Salazar, A. M., Lin, Y. K. & Ding, J. L., Feb 2 2021, In: International journal of molecular sciences. 22, 4, p. 1-23 23 p., 1626.Research output: Contribution to journal › Article › peer-review
Open Access16 Citations (Scopus)